![Pejvack Motlagh](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Pejvack Motlagh is currently Chief Medical Officer at Genfit SA since 2025.
Formerly, Dr. Motlagh was Chief Medical Officer at Egle Therapeutics SAS.
Actieve functies van Pejvack Motlagh
| Bedrijven | Functie | Begin |
|---|---|---|
| GENFIT | Hoofd Techniek/Wetenschap/O&O | 27-11-2025 |
Eerdere bekende functies van Pejvack Motlagh
| Bedrijven | Functie | Einde |
|---|---|---|
Egle Therapeutics SAS
 Egle Therapeutics SAS BiotechnologyHealth Technology Operates as a biotechnology company that designs modulate regulatory T cells to balance immunity for the treatment of cancer and autoimmune diseases | Hoofd Techniek/Wetenschap/O&O | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
21
Eerstegraads connecties
2
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Genfit SA
 Genfit SA BiotechnologyHealth Technology Engages in research and development of medicines and diagnostic solutions | Health Technology |
Egle Therapeutics SAS
Egle Therapeutics SAS BiotechnologyHealth Technology Operates as a biotechnology company that designs modulate regulatory T cells to balance immunity for the treatment of cancer and autoimmune diseases | Health Technology |
